Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
482 participants
OBSERVATIONAL
2014-06-01
2023-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Danish Audit of Small Bowel Obstruction
NCT04750811
Intrabdominal Pressure in Small Bowel Obstruction as a Possible Predictor for the Need of Operation
NCT01934283
Nasogastric Tube Clamping Trial vs. Immediate Removal
NCT04001985
Feasibility and Safety of an Ileus Management Protocol for Postoperative Ileus After Abdominal Surgery
NCT07194525
Comparison of Laparoscopic Surgery Versus Open Surgery in the Treatment of Adhesive Small Bowel Obstruction
NCT01867528
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnant
* Abdominal surgery within 30 days prior recruitment
* Inflammatory bowel disease
* Small bowel tumor causing obstruction
* Peritoneal carcinosis
* Intraluminal obstruction (bile stone, bezoar, etc.)
* Large bowel obstruction
* Small bowel obstruction caused by abdominal wall hernia
18 Years
120 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helsinki University Central Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ville Sallinen
MD, PhD, Adj. Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ville Sallinen
Role: PRINCIPAL_INVESTIGATOR
Helsinki University Central Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helsinki University Hospital, Jorvi hospital
Espoo, , Finland
Helsinki University Hospital, Meilahti hospital
Helsinki, , Finland
Hyvinkää Hospital
Hyvinkää, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SBO-DG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.